Fresenius SE & Co. (OTCMKTS:FSNUY) Sees Large Volume Increase – Still a Buy?

Posted by Donna Armstrong on Feb 27th, 2026

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) shares saw strong trading volume on Friday . 122,304 shares were traded during trading, an increase of 127% from the previous session’s volume of 53,801 shares.The stock last traded at $15.20 and had previously closed at $15.21.

Analyst Ratings Changes

A number of analysts have recently weighed in on FSNUY shares. Morgan Stanley reaffirmed an “overweight” rating on shares of Fresenius SE & Co. in a report on Monday, December 15th. Citigroup reaffirmed a “buy” rating on shares of Fresenius SE & Co. in a report on Tuesday, February 3rd. Three research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has an average rating of “Buy”.

Read Our Latest Research Report on FSNUY

Fresenius SE & Co. Trading Down 0.9%

The business’s 50 day simple moving average is $14.58 and its two-hundred day simple moving average is $14.40. The stock has a market cap of $33.96 billion, a P/E ratio of 23.93 and a beta of 0.75. The company has a quick ratio of 0.99, a current ratio of 1.26 and a debt-to-equity ratio of 0.49.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last issued its quarterly earnings data on Wednesday, February 25th. The company reported $0.28 earnings per share for the quarter. The business had revenue of $6.94 billion for the quarter. Fresenius SE & Co. had a return on equity of 10.38% and a net margin of 5.71%. As a group, analysts expect that Fresenius SE & Co. will post 0.79 EPS for the current year.

About Fresenius SE & Co.

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.